The Hib conjugate vaccine is highly effective, with clinical trials demonstrating over 95% efficacy in preventing invasive Hib disease. The vaccine has significantly reduced the incidence of Hib-related illnesses in many countries. For maximum effectiveness, the vaccine is typically administered in a series of doses starting at two months of age.
